Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cord Blood Transplantation Using Myeloablative Conditioning for Pediatric Advanced Myelodysplastic Syndrome in AMeD Syndrome With a Novel ADH5 Variant.
Morishita Y, Hamada M, Uemura S, Kikuchi H, Hisakawa H, Fujikawa T, Tamura A, Okuno Y, Wakamatsu M, Muramatsu H, Takahashi Y, Hasegawa D, Kosaka Y. Morishita Y, et al. Among authors: hasegawa d. Pediatr Blood Cancer. 2025 Feb;72(2):e31465. doi: 10.1002/pbc.31465. Epub 2024 Nov 30. Pediatr Blood Cancer. 2025. PMID: 39616414
Novel mutation in KIF23 causing congenital dyserythropoietic anemia type III in patients who underwent allogeneic hematopoietic stem cell transplantation.
Fujikawa T, Uemura S, Hasegawa D, Morisada N, Nakamura S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T, Yakushijin K, Katayama Y, Yamashita D, Wakamatsu M, Hamada M, Muramatsu H, Takahashi Y, Kosaka Y. Fujikawa T, et al. Among authors: hasegawa d. Pediatr Blood Cancer. 2024 Jun;71(6):e30736. doi: 10.1002/pbc.30736. Epub 2024 Mar 24. Pediatr Blood Cancer. 2024. PMID: 38523246 No abstract available.
[Successful non-myeloablative allogenic bone marrow transplantation in a child with severe congenital neutropenia complicated by chronic pulmonary infection].
Nino N, Kozaki A, Hasegawa D, Ueda G, Takahashi H, Miyata K, Ochi S, Yamashita T, Takafuji S, Uemura S, Yokoi T, Saito A, Ishida T, Kawasaki K, Nakamura K, Kobayashi M, Kosaka Y. Nino N, et al. Among authors: hasegawa d. Rinsho Ketsueki. 2016 Jun;57(6):742-7. doi: 10.11406/rinketsu.57.742. Rinsho Ketsueki. 2016. PMID: 27384854 Japanese.
Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1.
Tamura A, Uemura S, Yamamoto N, Saito A, Kozaki A, Kishimoto K, Ishida T, Hasegawa D, Hiroki H, Okano T, Imai K, Morio T, Kanegane H, Kosaka Y. Tamura A, et al. Among authors: hasegawa d. Allergy Asthma Clin Immunol. 2018 Nov 14;14:82. doi: 10.1186/s13223-018-0306-1. eCollection 2018. Allergy Asthma Clin Immunol. 2018. PMID: 30459818 Free PMC article.
Spindle cell sarcoma with KIAA1549-BRAF resembling infantile fibrosarcoma morphologically: A case report and literature review.
Fujikawa T, Uemura S, Yoshida M, Hyodo S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T, Uematsu A, Morita K, Hatakeyama T, Tamura A, Yamamoto N, Komatsu M, Soejima T, Hasegawa D, Kosaka Y. Fujikawa T, et al. Among authors: hasegawa d. Oncol Lett. 2022 Nov 1;24(6):452. doi: 10.3892/ol.2022.13572. eCollection 2022 Dec. Oncol Lett. 2022. PMID: 36380878 Free PMC article.
Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high‑risk neuroblastoma: A case report.
Inoue S, Win KHN, Mon CY, Fujikawa T, Hyodo S, Uemura S, Ishida T, Mori T, Hasegawa D, Kosaka Y, Nishimura A, Nakatani N, Nino N, Tamura A, Yamamoto N, Nozu K, Nishimura N. Inoue S, et al. Among authors: hasegawa d. Oncol Lett. 2023 Jul 14;26(3):369. doi: 10.3892/ol.2023.13955. eCollection 2023 Sep. Oncol Lett. 2023. PMID: 37559575 Free PMC article.
555 results